Teijin Ltd ADR (TINLY) 33.4700 $TINLY
Europe Polycarbonate Market by Application, and Geography - Trends & Forecast to 2019 for the $1.9 Billion Industry
M2 - Thu Oct 08, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4scmwj/europe) has announced the addition of the "Europe Polycarbonate Market by Application, and Geography - Trends & Forecast to 2019" report to their offering. The market size in terms of value of polycarbonate was estimated to be $1,900.0 million in 2014 and is projected to grow at a CAGR of about 5% from 2014 to 2019 The total market for Europe polycarbonate has been analyzed. The value chain describes the key contributors to the materials market at different stages from product development to end use. It represents the top players who are contributing to the Europe polycarbonate industry. The impact of different market factors, such as drivers, inhibitors, and opportunities is also illustrated in the report. This gives an idea about the key drivers such as increasing demand from automotive industry, large scale demand of consumer electronics & gadgets and optical media storage, & adaptability of polycarbonate in major end-user markets, and inhibitors such as adverse effects on the human health and hence the material is banned from use in the European region. The European polycarbonate market is also classified based on different applications. The important applications in end-use segments include automotive, consumer goods, electrical & electronic, medical, optical media, packaging, sheet film, and others (aerospace, gadgets, and so on) The consumer goods application segment is expected to witness rapid growth in the future. The key companies in this market are Bayer Material Science AG (Germany), SABIC IP. (the Netherlands), and Trinseo (Germany) among others. These companies are consistently focusing on expanding their production capacity to achieve competitive advantage and thereby serve the customers more effectively. Investments in the expansion of plant capacities, product portfolio expansion, followed by acquisitions were the most preferred strategies by the top players in 2013 & 2014 that are driving the demand of polycarbonate. Their strategy to capture the market in developing economies includes expansions, agreements, and product developments. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Europe Polycarbonate Market, By Application 6 Polycarbonate Market, By Country 7 Polycarbonate Market: Competitive Landscape 8 Polycarbonate Market, By Company - Bayer Materialscience - Mitsubishi Engineering Plastics Corporation - Sabic Innovative Plastics - Teijin Limited - Trinseo For more information visit http://www.researchandmarkets.com/research/4scmwj/europe
Vasculitis Pipeline Review, H2 2015 - 14 Companies & 12 Drug Profiles
M2 - Wed Oct 07, 3:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pxnvm5/vasculitis) has announced the addition of the "Vasculitis - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AnGes MG, Inc. - Aprogen, Inc. - ChemoCentryx, Inc. - Epirus Biopharmaceuticals, Inc. - F. Hoffmann-La Roche Ltd. - GlaxoSmithKline Plc - Hemostemix Ltd - K-Stemcell Co., Ltd. - Panacea Biotec Limited - Pfizer Inc. - Sandoz International GmbH - Stempeutics Research Private Limited - Teijin Pharma Limited - XOMA Corporation Drug Profiles - ACP-01 - belimumab - beperminogene perplasmid - CCX-168 - gevokizumab - immune globulin (human) - Monoclonal Antibodies to Antagonize GPR4 for Vascular Inflammation - PF-1355 - rituximab biosimilar - Stempeucel - tocilizumab - Vascostem For more information visit http://www.researchandmarkets.com/research/pxnvm5/vasculitis
PFE: 33.24 (+0.15), CCXI: 6.45 (+0.02), GSK: 40.22 (+0.06), XOMA: 0.99 (+0.04)
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development
M2 - Tue Oct 06, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h6w3sm/buccal_drug) has announced the addition of the "Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development" report to their offering. Buccal drug delivery is a promising area for continued research with the aim of systemic delivery of orally inefficient drugs as well as a feasible and attractive alternative for non-invasive delivery of potent peptide and protein drug molecules. In 2014, sales of Suboxone sublingual film totalled approximately $1.3 billion in the U.S. while the total market grew to more than $1.7 billion, driven by a 11 percent increase in prescriptions. In 2014, Bunavail buccal film has received US approval which has similar bioavailability of suboxone with half of the dose of buprenorphine. Other than drugs used for local actions (antifungal, antiviral), generally controlled substances like buprenorphine, naloxone and fentanyl are preferred to release the drug through buccal formulations. However, testosterone (striant) to treat low testosterone levels in men also approved through use of buccal system of delivery. In the US, drugs such as Isosorbide dinitarte, ergoloid delivered sublingually have been discontinued and nitroglycerin has been replaced with sublingual metered spray. Ergomar (ergotamine tartarate) marketed by Rosedale therapeutics is the only sublingual tablets available in the US market, priced $15 per pill. Subsys (fentanyl) developed by Insys therapeutics was the recent sublingual spray approved in the US for the treatment of breakthrough cancer pain. Global pharma companies such as Biodelivery Sciences, Bioalliance pharma (Onexo), Meda pharma, Orexo, Generex, Teijin are actively involved in developing oral mucoadhesive buccal delivery systems while sublingual technology have been used by Teva, Sun pharma, Grunenthal, Neurax, Angelini, Sandoz, Ethypharm, Arrow generics, Purdue and Actavis pharma. Sublingual spray technology have been employed by the companies such as Insys therapeutics, Perrigo, Mist pharm, Regency, Novadel, Generex, GW Pharma and Pohl Boskamp in developing potential drugs for the patients. Ease of administration and better compliance offered by delivering through buccal route offers advantages for patients and physicians over other Invasive route and oral ingestion will drive the market further in positive directions going forward. Novel buccal delivery such as soluble thin films, mucoadhesive films and rapidmist spray offers newer route of delivery for the generics that has lesser patients compliances. This report will provide detailed analysis on buccal delivery systems in broader pharma market in finding companies and technologies and complexities involved in developing this unique high potential delivery system. Key Topics Covered: 1. Introduction 2. Types of dosage forms 3. Transmucosal Delivery Systems: The Mouth 4. Potential Benefits of Buccal Films 5. Limitations and Challenges of Buccal delivery system 6. Buccal Films 7. Buccal Tablets 8. Sublingual films/Tablets 9. Other technologies used in buccal delivery systems 10. Oral Thin fast Dissolving Films (OTF) - Ideal Characteristics, Classification and Evaluation Companies Covered - Actavis - Angelini - Applied Pharma Research - Ardana Biosciences - Auxillium Pharma - Barr - Biodelivery Sciences - Blue fish - Cynapsus Pharma - Ethypharm - Galena - Galenica - Generex - Grunenthal - Indivior - Insys - Insys Therapeutics - IntelGenx - Intellidrug - LTS Lohmann - Meda Pharma - Mist Pharma - Mystic Pharma - Neuraxpharm - Novadel - Novel Labs - Nycomed - Roxane - Sandoz - Sanofi - Snoreeze - Tapemark - Tesa Labtec Pharma - Teva For more information visit http://www.researchandmarkets.com/research/h6...uccal_drug
INSY: 25.65 (+0.64)
Emerging Opportunities for Advance Fiber Market 2015-2019: Global Breakdown by Fiber Type, Application, Geography, and Market Share Analysis
M2 - Mon Oct 05, 2:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78cb6f/emerging) has announced the addition of the "Emerging Opportunities for Advance Fiber Market Globally (2010-2019): Breakdown by Fiber Type, Application, Geography, and Market Share Analysis" report to their offering. Increasing requirements for light weight requirements and highly focusing on the strength-to-weight ratio in manufacturing process by the major OEM's in all emerging markets such as Automotive, Aerospace, energy, Marine and consumer goods globally. The advance fiber will improve the technical properties, provides extraordinary strength, and efficiency of the applications. The requirement for advance fiber was observed tremendous growth in last few years, due to increase consumption, demand increasing light weight products, and highly focusing on research and development. The advanced fiber market is classified into glass fiber, carbon fiber, aramid fiber and others. Rapid growth of the advance fiber market is expected to bring forth opportunities as well as challenges for the key players in the market. The world's leading carbon fiber manufacturers for automotive and aerospace Industry were found to closely monitor competitive activities in an attempt to navigate the landscape more efficiently and garner higher market share. In virtually every respect, these producers are seeking to establish a tangible competitive advantage in the marketplace through the implementation of innovative strategies and creative product development capabilities. The global advance fiber market is characterized as highly competitive market and includes China Fiber glass Company Limited, Advanced Glassfiber Yarns LLC, Nippon Sheet Glass Co., Ltd, Guardian Fiberglass Inc., Owens Corning Inc., PPG Industries Inc., Taishan Fiberglass Inc., Toray Industries, Toho Tenax Co. Ltd.(Teijin), Mitsubishi - Rayon Co. Ltd. (MRC), Zoltek Companies Inc., Hexcel, SGL Group, Cytec Industries and others. Key Topics Covered: 1 Executive Summary 2 Advance Fiber - Definition 3 Report Briefing 4 Global Analysis On Advance Fiber Market 5 Value Chain Analysis 6 Cost Breakdown Analysis 7 Raw Material Consumption Analysis 8 Analysis On Fiber Type In Global Advance Fiber Market 9 Pricing Trend Analysis On Types Of Advance Fibers 10 Analysis On Porter's Five Force - Global Advance Fiber Market 11 Analysis On Top Five Emerging Country Analysis 12 Competitive Landscape And Major Company Promotional Strategies 13 Suppliers Landscape And Profiles 14 Key Market Developments - 2010-2015 15 Appendix For more information visit http://www.researchandmarkets.com/research/78cb6f/emerging
OC: 42.10 (-0.70), PPG: 95.97 (+0.20)
Carbon Fiber Market 2019 Forecasts With Coverage on Toray Industries Inc., Zoltek Companies Inc., Teijin Limited, Hexcel and Cytec Industries Inc.
PR Newswire Europe - Thu Oct 01, 9:01PM CDT
PUNE, India, October 2, 2015 /PRNewswire/ --
CYT: 74.02 (+0.09)
Teijin to Collaborate with PeptiDream in Peptide Discovery
M2 - Mon Sep 28, 6:29AM CDT
Teijin Pharma Limited, the core company of the Teijin Groups medical and pharmaceutical business, announced today that it has agreed with PeptiDream Inc., a Tokyo-based biopharmaceutical company, to jointly research and develop macrocyclic and constrained peptides.
Global Transparent Plastics PS, PP, PC, TPU, PVC, ABS, SAN, PMMA & Others) Market 2015 - Trends & Forecasts to 2020
M2 - Mon Sep 28, 6:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nbrxvv/transparent) has announced the addition of the "Transparent Plastics Market by Type, by Application & by Region - Trends & Forecasts to 2020" report to their offering. In terms of value, the global transparent plastics market is projected to grow at a CAGR of 6.4% from 2015 to reach a market size of around USD 165.2 Billion by 2020 The report on transparent plastics includes nine different types of glasses. These are polystyrene, polycarbonate, polypropylene, polyvinyl chloride, polymethyl methacrylate, thermoplastic polyurethane, acrylonitrile butadiene styrene, and styrene acrylonitrile. The global transparent plastics market is witnessing high growth because of the stringent norms & regulations, improved quality of end products, and growing demand in Asia-pacific & RoW. Transparent plastics are largely used in the packaging industry, in order to improve the shelf-life of packaged products. The increasing building safety codes and other regulations in major markets, along with increasing demand for energy-efficient buildings are driving the market for transparent plastics. Transparent plastics have the advantage of being lightweight and cost-effective over the traditional materials used in building & construction applications. Transparent plastics are finding increasing acceptance in the building & construction industry due to their properties such as durability, aesthetics, high performance, and easy handling. Plastics provide competitive energy efficiency, aesthetics, and design flexibility compared to glass. The use of transparent plastics in the building & construction industry also results in reduced heating and cooling costs along with providing protection against extreme weather. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Transparent Plastics Market, By Type 8 Transparent Plastics Market, By Application 9 Transparent Plastics Market, By Region 10 Competitive Landscape 11 Company Profiles - BASF SE - Bayer AG - E.I. Du Pont De Nemours & Co - Evonik Industries AG - Lanxess A.G. - Lyondellbasell Industries N.V. - PPG Industries - Sabic Innovative Plastics Us Llc - Teijin Ltd - The DOW Chemical Company For more information visit http://www.researchandmarkets.com/research/nb...ransparent
DD: 56.18 (+0.05), PPG: 95.97 (+0.20)
PeptiDream Announces Peptide Discovery Collaboration Agreement with Teijin Pharma
Business Wire - Sun Sep 27, 11:47PM CDT
PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream"
(TOKYO:4587) today announced a multi-target discovery and optimization collaboration with Teijin Pharma Limited, Tokyo, Japan ("Teijin" (TSE: 3401). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to generate macrocyclic/constrained peptides against multiple targets of interest selected by Teijin. Teijin will have the right to develop and commercialize all therapeutic peptides resulting from the collaboration. In addition, Teijin will have the rights to use the macrocyclic/constrained peptides identified during the collaboration as starting compounds for the development of small molecules therapeutics against the collaboration targets. PeptiDream will receive an undisclosed upfront payment, research funding and will be eligible for payments associated with the achievement of certain preclinical and clinical development milestones. In addition, PeptiDream is eligible to receive royalties on sales of any products that arise from the collaboration.
Teijin Aramid Stops Research for New Aramid Copolymers Containing DAPBI
PR Newswire Europe - Wed Sep 23, 8:02AM CDT
ARNHEM, Netherlands, September 23, 2015 /PRNewswire/ --
Nanofibers Market Report 2015-2020: The Key Market Trends, Growth Drivers & Challenges
M2 - Tue Sep 22, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtzg3j/nanofibers) has announced the addition of the "Nanofibers - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Nanofibers in US$ Thousand. The Global market is further analyzed by the following End-Use Segments: Energy, Chemical/Mechanical, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as - Applied Sciences, Inc. (US) - Argonide Corporation (US) - Ahlstrom Corporation (Finland) - Asahi Kasei Fibers Corporation (Japan) - Catalytic Materials LLC (US) - Daicel FineChem Ltd. (Japan) - Donaldson Company, Inc. (US) - E. I. du Pont de Nemours and Company (US) - Dreamweaver International (US) - Elmarco (Czech Republic) - eSpin Technologies, Inc. (US) - Finetex EnE, Inc. (Korea) - FibeRio Technology Corporation (US) - Grupo Antolin (Spain) - Hollingsworth and Vose (US) - Japan Vilene Company Ltd. (Japan) - Johns Manville (US) - Reade Advanced Materials (US) - Showa Denko K.K. (Japan) - Teijin Limited (Japan) - Toray Industries, Inc. (Japan) - Wooree Nanophil Co. Ltd. (Korea) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. KEY MARKET TRENDS, GROWTH DRIVERS & CHALLENGES 3. PRODUCT OVERVIEW 4. PRODUCT LAUNCHES/APPROVALS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 42 (including Divisions/Subsidiaries - 43) - The United States (20) - Canada (1) - Japan (7) - Europe (7) - - Spain (1) - - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (4) - Africa (2) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/dtzg3j/nanofibers
DCI: 30.49 (+0.05)
Global Peripheral Neuropathy (Sensory Neuropathy) Pipeline Review 2015 - 10 Companies & 15 Drug Profiles
M2 - Tue Sep 08, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/32f36p/peripheral) has announced the addition of the "Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Arcturus Therapeutics, Inc - aTyr Pharma, Inc. - GeNeuro SA - INSYS Therapeutics, Inc. - Mitsubishi Tanabe Pharma Corporation - Neuren Pharmaceuticals Limited - Pfizer Inc. - Polyneuron Pharmaceuticals AG - RegeneRx Biopharmaceuticals, Inc. - Teijin Pharma Limited Drug Profiles - (immune globulin (human) hyaluronidase (recombinant)) - Cannabidiol - fingolimod hydrochloride - GL-2045 - immune globulin (human) - immune globulin (human) - LUNAR-102 - Monoclonal Antibody for CIDP - NNZ-2591 - Peptide to Activate GLP1R for CNS, Metabolic Disorders and Head Trauma - Peptides to Activate GLP-1 Receptor for CNS Disorders and Head Trauma - PN-1007 - Proteins for Inflammation, Hematological, Metabolic, Oncology, Neurodegenerative and Cardiovascular Disorder - RGN-352 - Synthetic Peptides for Peripheral Neuropathy For more information visit http://www.researchandmarkets.com/research/32f36p/peripheral
INSY: 25.65 (+0.64), PFE: 33.24 (+0.15)
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2015
M2 - Fri Sep 04, 5:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lm42zr/microscopic) has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Microscopic Polyangiitis (MPA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Microscopic Polyangiitis (MPA) and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to Buy The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Mentioned - Aprogen - ChemoCentryx - Epirus Biopharmaceuticals - GlaxoSmithKline - Panacea Biotec - Sandoz International - Teijin Pharma For more information visit http://www.researchandmarkets.com/research/lm...icroscopic
GSK: 40.22 (+0.06)
Global Protective Clothing Market Is Expected To Register A CAGR Of 6.2% In The Next Five Years To Reach $9.3 Billion By 2020, New Report Says
M2 - Thu Sep 03, 9:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lvnw2s/protective) has announced the addition of the "Protective Clothing Market by Type (Aramid & Blends, Polyolefin & Blends, Polyamide, and PBI), by Application (Thermal, Chemical, and Visibility), and by End Use Industries - Global Forecast to 2020" report to their offering. The protective clothing market is expected to register a CAGR of 6.2% in the next five years, to reach $9.3 Billion by 2020. Protective clothing is designed to protect the person against industrial hazards during any operation. Each industry requires specific kind of protective clothing, such as thermal protective clothing, chemical protective clothing, mechanical protective clothing, biological/radiation protective clothing, and visibility protective clothing. These protective clothing safeguard from from fire, electrical, chemical, biohazards, physical, cold, and explosives. Thermal application comprise the major application of protective clothing, followed by visibility and mechanical. Thermal application accounted for 26.7% share of the said market in 2014. The biological/radiation application of protective clothing is projected to witness the highest CAGR of 12.0% between 2015 and 2020. North America is projected to continue to lead the protective clothing market till 2020, followed by Europe and Asia-Pacific. This is mainly due to the presence of significant growth of end-user industries for oil & gas, construction & manufacturing, heakthcare/medical and mining which uses protective clothing, in developed economies, such as U.S., Germany, and U.K. Asia-Pacific and Latin America are the fastest-growing market for protective clothing due to emerging industris in developing economies, such China, India, and Brazil. Key Topics Covered - Introduction - Research Methodology - Executive Summary - Premium Insights - Market Overview - Industry Trends - Protective Clothing Market, By Application - Protective Clothing Market, By Type - Protective Clothing Market, By End-Use Industry - Protective Clothing Market, By User Type - Protective Clothing Market, By Region - Competitive Landscape - Company Profiles - Appendix Companies Mentioned - 3M CO - Ansell - E. I. Du Pont De Nemours And Co. - Globe Manufacturing - Honeywell International - Kimberly Clark - Lakeland Industries - Lion Apparel - PBI Performance Products - Royal Ten Cate - Sioen Industries - Teijin - W. L. Gore & Associates - Workrite Uniform Company For more information visit http://www.researchandmarkets.com/research/lvnw2s/protective
MMM: 149.90 (+0.42), HON: 101.16 (+0.09), LAKE: 13.59 (-0.28)
Can Under Armour (UA) Tide Over Foreign Currency Woes?
Zacks Equity Research - Zacks Investment Research - Mon Aug 31, 1:00PM CDT
Can Under Armour (UA) tide over foreign currency woes based on its development initiatives?
UA: 102.32 (+1.18), PERY: 21.95 (+0.32), COLM: 58.42 (-0.32)
PVH Jumps on Q2 Earnings & Sales Beat; Raises FY15 View
Zacks Equity Research - Zacks Investment Research - Thu Aug 27, 9:20AM CDT
PVH Corp. (PVH) rises on better-than-expected second-quarter fiscal 2015 results; Raises fiscal 2015 outlook.
PERY: 21.95 (+0.32), COLM: 58.42 (-0.32), PVH: 100.64 (-0.96)
DuPont Announces Senior Leadership Changes
PR Newswire - Tue Aug 25, 12:38PM CDT
Today DuPont announced that it has named John L. Chrosniak, President, DuPont Sustainable Solutions effective Sept. 1, succeeding James R. (Jim) Weigand, who has been appointed Chairman & CEO of the DuPont Teijin Films joint venture.
DD: 56.18 (+0.05)
Global Carbon Fiber Reinforced Plastic Market 2015 Report
M2 - Wed Aug 19, 10:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qw8w5m/global_carbon) has announced the addition of the "Global Carbon Fiber Reinforced Plastic (CFRP) Market 2015-2019" report to their offering. Global CFRP Market to Grow at a CAGR of 13.07% over the Period 2014-2019 The fluctuating price of fuel drives the market for electric and hybrid vehicles, in which CFRP materials are used as they are lightweight and balance the heavy engines and motors used in the body. The use of CFRP in the manufacture of high-performance vehicle components such as chassis, hoods, wheels, and roofs also drives market growth. According to the report, the fluctuating price of fuel drives the market for electric and hybrid vehicles, in which CFRP materials are used as they are lightweight and balance the heavy engines and motors used in the body. The use of CFRP in the manufacture of high-performance vehicle components such as chassis, hoods, wheels, and roofs also drives market growth. Further, the report states that the high cost of carbon fiber hinders market growth. Key Topics Covered - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Global CFRP Market - Market Segmentation by Type - Market Segmentation by Raw Material - Market Segmentation by Application - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Composite Holding - Crosby Composites - Cytec Industries - DowAksa - Formosa Plastics - GKN Aerospace - Gurit Holdings - Hexcel - Hyosung - Kringlan Composites - Mitsubishi Rayon Carbon Fiber and Composite - Nippon Graphite Fibre - Plasan Carbon Composites - SGL Group - Teijin - Tencate - Toho Tenax America - Toray industries - Zoltek For more information visit http://www.researchandmarkets.com/research/qw...bal_carbon
CYT: 74.02 (+0.09)
Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Wed Aug 19, 3:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nl6c3p/stationary_oxygen) has announced the addition of Wintergreen Research, Inc's new report "Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Oxygen concentrator markets at $669.5 million in 2014 are anticipated to reach $2 billion dollars by 2021. Growth is a result of new competitors in the market, demand for the smaller lighter technology by patients, and the market need by for stationary devices at home even as portable devices provide greater mobility support for older people. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. Stationary oxygen concentrators are needed for night use by patients on portable oxygen concentrators during the day. People on oxygen wish to continue usual activities, the portable devices are useful for that during the day. Distributors are concentrated on determining which stationary oxygen concentrator supports patient lifestyle. Major factors driving the market for stationary oxygen concentrators include its ability to provide oxygen under all circumstances. The worldwide aging population. An increase in the number of people with COPD and other respiratory diseases. Advantages of newer stationary oxygen concentrator devices are that they weigh less, are somewhat quieter than toe older units, and are easy to use. They are generally affordable but reimbursement drives markets. There has been a quantum improvement in the home based stationary oxygen concentrator technology. Less weight, more power are the characteristics of the new stationary units. The huge jump in technology is illustrated by the effectiveness of the devices in providing improved patient lifestyle. Stationary concentrator systems are always used by a patient to supplement portable oxygen concentrators. Portable oxygen must be supplemented with standard large, bulky, and inefficient, heavy, and impractical stationary devices because the stationary devices provide a more stable source of oxygen during sleep. Key Topics Covered: 1. Stationary Oxygen Concentrator Market Description and Market Dynamics 2 Stationary Oxygen Concentrator Market Shares and Forecasts 3. Stationary Oxygen Concentrator Product Description 4 Stationary Oxygen Concentrator Technology 5 Stationary Oxygen Concentrator Company Profiles Market Leaders: - AirSep - Chart / Caire / SeQual - Invacare - Philips Respironics Market Participants: - Air Liquide - Braun and Company - CAIRE / SeQual Technologies - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - O2Concepts Oxlife - OSI Systems - ResMed - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Troope For more information visit http://www.researchandmarkets.com/research/nl...ary_oxygen Source: Wintergreen Research, Inc
IVC: 16.23 (-0.06), CFN: 59.91 (-0.06), TFX: 125.79 (+0.64), OSIS: 82.71 (+0.13)
Global Carbon Fiber Market 2015-2019 - Analyzes the Potential Opportunities and Significant Trends in the Industry
M2 - Tue Aug 18, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fj9pwb/global_carbon) has announced the addition of the "Global Carbon Fiber Market: Trends and Opportunities (2015-2019)" report to their offering. The report titled Carbon Fiber Market: Trends & Opportunities (2015-2019), analyzes the potential opportunities and significant trends in the carbon fiber industry. The report provides detailed analysis of market sizing and growth of carbon fiber by various applications for the period 2010-2014. The Industrial segment is expected to be the fastest growing segment for the next 5 years, due to technical advances. Furthermore, in carbon fiber production, USA has the highest market share. The report also provides detailed market share analysis of the carbon fiber demand and supply. The market forecast in value terms for carbon fiber market has been provided for the period 2015 to 2019, considering 2014 as the base year. The report also provides compounded annual growth rate (% CAGR) for the forecast period 2015 to 2019. Over the next five years, Carbon fiber market revenues are forecasted to grow with the wide usage in the wind energy sector in the coming years. The report provides detailed country analysis of China carbon fiber market in terms of value, capacity and areas of application. And the report also profiles key market players such as Toray Industries Inc., Zoltek Companies Inc., Teijin Limited, Hexcel and Cytec Industries Inc. on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments. Company Coverage - Toray Industries Inc. - Zoltek Companies Inc. - Teijin Limited - Hexcel - Cytec Industries Inc. Key Topics Covered: 1.Executive Summary 2. Carbon Fiber: An Introduction 3. Global Carbon Fiber Market: An Analysis 4. Global Carbon Fiber Market Share: An Analysis 5. Carbon Fiber Market of China: An Analysis 6. Market Dynamics: Carbon Fiber Market 7. Competitive Landscape:Carbon Fiber Market 8. Company Profiles:Carbon Fiber Market For more information visit http://www.researchandmarkets.com/research/fj...bal_carbon
CYT: 74.02 (+0.09)
Europe Polycarbonate Market by Application, and Geography - Trends & Forecast to 2019 for the $1.9 Billion Industry
M2 - Thu Oct 08, 8:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4scmwj/europe) has announced the addition of the "Europe Polycarbonate Market by Application, and Geography - Trends & Forecast to 2019" report to their offering. The market size in terms of value of polycarbonate was estimated to be $1,900.0 million in 2014 and is projected to grow at a CAGR of about 5% from 2014 to 2019 The total market for Europe polycarbonate has been analyzed. The value chain describes the key contributors to the materials market at different stages from product development to end use. It represents the top players who are contributing to the Europe polycarbonate industry. The impact of different market factors, such as drivers, inhibitors, and opportunities is also illustrated in the report. This gives an idea about the key drivers such as increasing demand from automotive industry, large scale demand of consumer electronics & gadgets and optical media storage, & adaptability of polycarbonate in major end-user markets, and inhibitors such as adverse effects on the human health and hence the material is banned from use in the European region. The European polycarbonate market is also classified based on different applications. The important applications in end-use segments include automotive, consumer goods, electrical & electronic, medical, optical media, packaging, sheet film, and others (aerospace, gadgets, and so on) The consumer goods application segment is expected to witness rapid growth in the future. The key companies in this market are Bayer Material Science AG (Germany), SABIC IP. (the Netherlands), and Trinseo (Germany) among others. These companies are consistently focusing on expanding their production capacity to achieve competitive advantage and thereby serve the customers more effectively. Investments in the expansion of plant capacities, product portfolio expansion, followed by acquisitions were the most preferred strategies by the top players in 2013 & 2014 that are driving the demand of polycarbonate. Their strategy to capture the market in developing economies includes expansions, agreements, and product developments. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Europe Polycarbonate Market, By Application 6 Polycarbonate Market, By Country 7 Polycarbonate Market: Competitive Landscape 8 Polycarbonate Market, By Company - Bayer Materialscience - Mitsubishi Engineering Plastics Corporation - Sabic Innovative Plastics - Teijin Limited - Trinseo For more information visit http://www.researchandmarkets.com/research/4scmwj/europe
Vasculitis Pipeline Review, H2 2015 - 14 Companies & 12 Drug Profiles
M2 - Wed Oct 07, 3:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pxnvm5/vasculitis) has announced the addition of the "Vasculitis - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AnGes MG, Inc. - Aprogen, Inc. - ChemoCentryx, Inc. - Epirus Biopharmaceuticals, Inc. - F. Hoffmann-La Roche Ltd. - GlaxoSmithKline Plc - Hemostemix Ltd - K-Stemcell Co., Ltd. - Panacea Biotec Limited - Pfizer Inc. - Sandoz International GmbH - Stempeutics Research Private Limited - Teijin Pharma Limited - XOMA Corporation Drug Profiles - ACP-01 - belimumab - beperminogene perplasmid - CCX-168 - gevokizumab - immune globulin (human) - Monoclonal Antibodies to Antagonize GPR4 for Vascular Inflammation - PF-1355 - rituximab biosimilar - Stempeucel - tocilizumab - Vascostem For more information visit http://www.researchandmarkets.com/research/pxnvm5/vasculitis
PFE: 33.24 (+0.15), CCXI: 6.45 (+0.02), GSK: 40.22 (+0.06), XOMA: 0.99 (+0.04)
Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development
M2 - Tue Oct 06, 5:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/h6w3sm/buccal_drug) has announced the addition of the "Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Development" report to their offering. Buccal drug delivery is a promising area for continued research with the aim of systemic delivery of orally inefficient drugs as well as a feasible and attractive alternative for non-invasive delivery of potent peptide and protein drug molecules. In 2014, sales of Suboxone sublingual film totalled approximately $1.3 billion in the U.S. while the total market grew to more than $1.7 billion, driven by a 11 percent increase in prescriptions. In 2014, Bunavail buccal film has received US approval which has similar bioavailability of suboxone with half of the dose of buprenorphine. Other than drugs used for local actions (antifungal, antiviral), generally controlled substances like buprenorphine, naloxone and fentanyl are preferred to release the drug through buccal formulations. However, testosterone (striant) to treat low testosterone levels in men also approved through use of buccal system of delivery. In the US, drugs such as Isosorbide dinitarte, ergoloid delivered sublingually have been discontinued and nitroglycerin has been replaced with sublingual metered spray. Ergomar (ergotamine tartarate) marketed by Rosedale therapeutics is the only sublingual tablets available in the US market, priced $15 per pill. Subsys (fentanyl) developed by Insys therapeutics was the recent sublingual spray approved in the US for the treatment of breakthrough cancer pain. Global pharma companies such as Biodelivery Sciences, Bioalliance pharma (Onexo), Meda pharma, Orexo, Generex, Teijin are actively involved in developing oral mucoadhesive buccal delivery systems while sublingual technology have been used by Teva, Sun pharma, Grunenthal, Neurax, Angelini, Sandoz, Ethypharm, Arrow generics, Purdue and Actavis pharma. Sublingual spray technology have been employed by the companies such as Insys therapeutics, Perrigo, Mist pharm, Regency, Novadel, Generex, GW Pharma and Pohl Boskamp in developing potential drugs for the patients. Ease of administration and better compliance offered by delivering through buccal route offers advantages for patients and physicians over other Invasive route and oral ingestion will drive the market further in positive directions going forward. Novel buccal delivery such as soluble thin films, mucoadhesive films and rapidmist spray offers newer route of delivery for the generics that has lesser patients compliances. This report will provide detailed analysis on buccal delivery systems in broader pharma market in finding companies and technologies and complexities involved in developing this unique high potential delivery system. Key Topics Covered: 1. Introduction 2. Types of dosage forms 3. Transmucosal Delivery Systems: The Mouth 4. Potential Benefits of Buccal Films 5. Limitations and Challenges of Buccal delivery system 6. Buccal Films 7. Buccal Tablets 8. Sublingual films/Tablets 9. Other technologies used in buccal delivery systems 10. Oral Thin fast Dissolving Films (OTF) - Ideal Characteristics, Classification and Evaluation Companies Covered - Actavis - Angelini - Applied Pharma Research - Ardana Biosciences - Auxillium Pharma - Barr - Biodelivery Sciences - Blue fish - Cynapsus Pharma - Ethypharm - Galena - Galenica - Generex - Grunenthal - Indivior - Insys - Insys Therapeutics - IntelGenx - Intellidrug - LTS Lohmann - Meda Pharma - Mist Pharma - Mystic Pharma - Neuraxpharm - Novadel - Novel Labs - Nycomed - Roxane - Sandoz - Sanofi - Snoreeze - Tapemark - Tesa Labtec Pharma - Teva For more information visit http://www.researchandmarkets.com/research/h6...uccal_drug
INSY: 25.65 (+0.64)
Emerging Opportunities for Advance Fiber Market 2015-2019: Global Breakdown by Fiber Type, Application, Geography, and Market Share Analysis
M2 - Mon Oct 05, 2:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/78cb6f/emerging) has announced the addition of the "Emerging Opportunities for Advance Fiber Market Globally (2010-2019): Breakdown by Fiber Type, Application, Geography, and Market Share Analysis" report to their offering. Increasing requirements for light weight requirements and highly focusing on the strength-to-weight ratio in manufacturing process by the major OEM's in all emerging markets such as Automotive, Aerospace, energy, Marine and consumer goods globally. The advance fiber will improve the technical properties, provides extraordinary strength, and efficiency of the applications. The requirement for advance fiber was observed tremendous growth in last few years, due to increase consumption, demand increasing light weight products, and highly focusing on research and development. The advanced fiber market is classified into glass fiber, carbon fiber, aramid fiber and others. Rapid growth of the advance fiber market is expected to bring forth opportunities as well as challenges for the key players in the market. The world's leading carbon fiber manufacturers for automotive and aerospace Industry were found to closely monitor competitive activities in an attempt to navigate the landscape more efficiently and garner higher market share. In virtually every respect, these producers are seeking to establish a tangible competitive advantage in the marketplace through the implementation of innovative strategies and creative product development capabilities. The global advance fiber market is characterized as highly competitive market and includes China Fiber glass Company Limited, Advanced Glassfiber Yarns LLC, Nippon Sheet Glass Co., Ltd, Guardian Fiberglass Inc., Owens Corning Inc., PPG Industries Inc., Taishan Fiberglass Inc., Toray Industries, Toho Tenax Co. Ltd.(Teijin), Mitsubishi - Rayon Co. Ltd. (MRC), Zoltek Companies Inc., Hexcel, SGL Group, Cytec Industries and others. Key Topics Covered: 1 Executive Summary 2 Advance Fiber - Definition 3 Report Briefing 4 Global Analysis On Advance Fiber Market 5 Value Chain Analysis 6 Cost Breakdown Analysis 7 Raw Material Consumption Analysis 8 Analysis On Fiber Type In Global Advance Fiber Market 9 Pricing Trend Analysis On Types Of Advance Fibers 10 Analysis On Porter's Five Force - Global Advance Fiber Market 11 Analysis On Top Five Emerging Country Analysis 12 Competitive Landscape And Major Company Promotional Strategies 13 Suppliers Landscape And Profiles 14 Key Market Developments - 2010-2015 15 Appendix For more information visit http://www.researchandmarkets.com/research/78cb6f/emerging
OC: 42.10 (-0.70), PPG: 95.97 (+0.20)
Carbon Fiber Market 2019 Forecasts With Coverage on Toray Industries Inc., Zoltek Companies Inc., Teijin Limited, Hexcel and Cytec Industries Inc.
PR Newswire Europe - Thu Oct 01, 9:01PM CDT
PUNE, India, October 2, 2015 /PRNewswire/ --
CYT: 74.02 (+0.09)
Teijin to Collaborate with PeptiDream in Peptide Discovery
M2 - Mon Sep 28, 6:29AM CDT
Teijin Pharma Limited, the core company of the Teijin Groups medical and pharmaceutical business, announced today that it has agreed with PeptiDream Inc., a Tokyo-based biopharmaceutical company, to jointly research and develop macrocyclic and constrained peptides.
Global Transparent Plastics PS, PP, PC, TPU, PVC, ABS, SAN, PMMA & Others) Market 2015 - Trends & Forecasts to 2020
M2 - Mon Sep 28, 6:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nbrxvv/transparent) has announced the addition of the "Transparent Plastics Market by Type, by Application & by Region - Trends & Forecasts to 2020" report to their offering. In terms of value, the global transparent plastics market is projected to grow at a CAGR of 6.4% from 2015 to reach a market size of around USD 165.2 Billion by 2020 The report on transparent plastics includes nine different types of glasses. These are polystyrene, polycarbonate, polypropylene, polyvinyl chloride, polymethyl methacrylate, thermoplastic polyurethane, acrylonitrile butadiene styrene, and styrene acrylonitrile. The global transparent plastics market is witnessing high growth because of the stringent norms & regulations, improved quality of end products, and growing demand in Asia-pacific & RoW. Transparent plastics are largely used in the packaging industry, in order to improve the shelf-life of packaged products. The increasing building safety codes and other regulations in major markets, along with increasing demand for energy-efficient buildings are driving the market for transparent plastics. Transparent plastics have the advantage of being lightweight and cost-effective over the traditional materials used in building & construction applications. Transparent plastics are finding increasing acceptance in the building & construction industry due to their properties such as durability, aesthetics, high performance, and easy handling. Plastics provide competitive energy efficiency, aesthetics, and design flexibility compared to glass. The use of transparent plastics in the building & construction industry also results in reduced heating and cooling costs along with providing protection against extreme weather. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Transparent Plastics Market, By Type 8 Transparent Plastics Market, By Application 9 Transparent Plastics Market, By Region 10 Competitive Landscape 11 Company Profiles - BASF SE - Bayer AG - E.I. Du Pont De Nemours & Co - Evonik Industries AG - Lanxess A.G. - Lyondellbasell Industries N.V. - PPG Industries - Sabic Innovative Plastics Us Llc - Teijin Ltd - The DOW Chemical Company For more information visit http://www.researchandmarkets.com/research/nb...ransparent
DD: 56.18 (+0.05), PPG: 95.97 (+0.20)
PeptiDream Announces Peptide Discovery Collaboration Agreement with Teijin Pharma
Business Wire - Sun Sep 27, 11:47PM CDT
PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream"
(TOKYO:4587) today announced a multi-target discovery and optimization collaboration with Teijin Pharma Limited, Tokyo, Japan ("Teijin" (TSE: 3401). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to generate macrocyclic/constrained peptides against multiple targets of interest selected by Teijin. Teijin will have the right to develop and commercialize all therapeutic peptides resulting from the collaboration. In addition, Teijin will have the rights to use the macrocyclic/constrained peptides identified during the collaboration as starting compounds for the development of small molecules therapeutics against the collaboration targets. PeptiDream will receive an undisclosed upfront payment, research funding and will be eligible for payments associated with the achievement of certain preclinical and clinical development milestones. In addition, PeptiDream is eligible to receive royalties on sales of any products that arise from the collaboration. Teijin Aramid Stops Research for New Aramid Copolymers Containing DAPBI
PR Newswire Europe - Wed Sep 23, 8:02AM CDT
ARNHEM, Netherlands, September 23, 2015 /PRNewswire/ --
Nanofibers Market Report 2015-2020: The Key Market Trends, Growth Drivers & Challenges
M2 - Tue Sep 22, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtzg3j/nanofibers) has announced the addition of the "Nanofibers - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Nanofibers in US$ Thousand. The Global market is further analyzed by the following End-Use Segments: Energy, Chemical/Mechanical, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as - Applied Sciences, Inc. (US) - Argonide Corporation (US) - Ahlstrom Corporation (Finland) - Asahi Kasei Fibers Corporation (Japan) - Catalytic Materials LLC (US) - Daicel FineChem Ltd. (Japan) - Donaldson Company, Inc. (US) - E. I. du Pont de Nemours and Company (US) - Dreamweaver International (US) - Elmarco (Czech Republic) - eSpin Technologies, Inc. (US) - Finetex EnE, Inc. (Korea) - FibeRio Technology Corporation (US) - Grupo Antolin (Spain) - Hollingsworth and Vose (US) - Japan Vilene Company Ltd. (Japan) - Johns Manville (US) - Reade Advanced Materials (US) - Showa Denko K.K. (Japan) - Teijin Limited (Japan) - Toray Industries, Inc. (Japan) - Wooree Nanophil Co. Ltd. (Korea) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. KEY MARKET TRENDS, GROWTH DRIVERS & CHALLENGES 3. PRODUCT OVERVIEW 4. PRODUCT LAUNCHES/APPROVALS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT GLOBAL PLAYERS 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 42 (including Divisions/Subsidiaries - 43) - The United States (20) - Canada (1) - Japan (7) - Europe (7) - - Spain (1) - - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (4) - Africa (2) - Middle East (2) For more information visit http://www.researchandmarkets.com/research/dtzg3j/nanofibers
DCI: 30.49 (+0.05)
Global Peripheral Neuropathy (Sensory Neuropathy) Pipeline Review 2015 - 10 Companies & 15 Drug Profiles
M2 - Tue Sep 08, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/32f36p/peripheral) has announced the addition of the "Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Arcturus Therapeutics, Inc - aTyr Pharma, Inc. - GeNeuro SA - INSYS Therapeutics, Inc. - Mitsubishi Tanabe Pharma Corporation - Neuren Pharmaceuticals Limited - Pfizer Inc. - Polyneuron Pharmaceuticals AG - RegeneRx Biopharmaceuticals, Inc. - Teijin Pharma Limited Drug Profiles - (immune globulin (human) hyaluronidase (recombinant)) - Cannabidiol - fingolimod hydrochloride - GL-2045 - immune globulin (human) - immune globulin (human) - LUNAR-102 - Monoclonal Antibody for CIDP - NNZ-2591 - Peptide to Activate GLP1R for CNS, Metabolic Disorders and Head Trauma - Peptides to Activate GLP-1 Receptor for CNS Disorders and Head Trauma - PN-1007 - Proteins for Inflammation, Hematological, Metabolic, Oncology, Neurodegenerative and Cardiovascular Disorder - RGN-352 - Synthetic Peptides for Peripheral Neuropathy For more information visit http://www.researchandmarkets.com/research/32f36p/peripheral
INSY: 25.65 (+0.64), PFE: 33.24 (+0.15)
Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2015
M2 - Fri Sep 04, 5:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lm42zr/microscopic) has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Microscopic Polyangiitis (MPA), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Microscopic Polyangiitis (MPA) and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to Buy The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Mentioned - Aprogen - ChemoCentryx - Epirus Biopharmaceuticals - GlaxoSmithKline - Panacea Biotec - Sandoz International - Teijin Pharma For more information visit http://www.researchandmarkets.com/research/lm...icroscopic
GSK: 40.22 (+0.06)
Global Protective Clothing Market Is Expected To Register A CAGR Of 6.2% In The Next Five Years To Reach $9.3 Billion By 2020, New Report Says
M2 - Thu Sep 03, 9:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lvnw2s/protective) has announced the addition of the "Protective Clothing Market by Type (Aramid & Blends, Polyolefin & Blends, Polyamide, and PBI), by Application (Thermal, Chemical, and Visibility), and by End Use Industries - Global Forecast to 2020" report to their offering. The protective clothing market is expected to register a CAGR of 6.2% in the next five years, to reach $9.3 Billion by 2020. Protective clothing is designed to protect the person against industrial hazards during any operation. Each industry requires specific kind of protective clothing, such as thermal protective clothing, chemical protective clothing, mechanical protective clothing, biological/radiation protective clothing, and visibility protective clothing. These protective clothing safeguard from from fire, electrical, chemical, biohazards, physical, cold, and explosives. Thermal application comprise the major application of protective clothing, followed by visibility and mechanical. Thermal application accounted for 26.7% share of the said market in 2014. The biological/radiation application of protective clothing is projected to witness the highest CAGR of 12.0% between 2015 and 2020. North America is projected to continue to lead the protective clothing market till 2020, followed by Europe and Asia-Pacific. This is mainly due to the presence of significant growth of end-user industries for oil & gas, construction & manufacturing, heakthcare/medical and mining which uses protective clothing, in developed economies, such as U.S., Germany, and U.K. Asia-Pacific and Latin America are the fastest-growing market for protective clothing due to emerging industris in developing economies, such China, India, and Brazil. Key Topics Covered - Introduction - Research Methodology - Executive Summary - Premium Insights - Market Overview - Industry Trends - Protective Clothing Market, By Application - Protective Clothing Market, By Type - Protective Clothing Market, By End-Use Industry - Protective Clothing Market, By User Type - Protective Clothing Market, By Region - Competitive Landscape - Company Profiles - Appendix Companies Mentioned - 3M CO - Ansell - E. I. Du Pont De Nemours And Co. - Globe Manufacturing - Honeywell International - Kimberly Clark - Lakeland Industries - Lion Apparel - PBI Performance Products - Royal Ten Cate - Sioen Industries - Teijin - W. L. Gore & Associates - Workrite Uniform Company For more information visit http://www.researchandmarkets.com/research/lvnw2s/protective
MMM: 149.90 (+0.42), HON: 101.16 (+0.09), LAKE: 13.59 (-0.28)
Can Under Armour (UA) Tide Over Foreign Currency Woes?
Zacks Equity Research - Zacks Investment Research - Mon Aug 31, 1:00PM CDT
Can Under Armour (UA) tide over foreign currency woes based on its development initiatives?
UA: 102.32 (+1.18), PERY: 21.95 (+0.32), COLM: 58.42 (-0.32)
PVH Jumps on Q2 Earnings & Sales Beat; Raises FY15 View
Zacks Equity Research - Zacks Investment Research - Thu Aug 27, 9:20AM CDT
PVH Corp. (PVH) rises on better-than-expected second-quarter fiscal 2015 results; Raises fiscal 2015 outlook.
PERY: 21.95 (+0.32), COLM: 58.42 (-0.32), PVH: 100.64 (-0.96)
DuPont Announces Senior Leadership Changes
PR Newswire - Tue Aug 25, 12:38PM CDT
Today DuPont announced that it has named John L. Chrosniak, President, DuPont Sustainable Solutions effective Sept. 1, succeeding James R. (Jim) Weigand, who has been appointed Chairman & CEO of the DuPont Teijin Films joint venture.
DD: 56.18 (+0.05)
Global Carbon Fiber Reinforced Plastic Market 2015 Report
M2 - Wed Aug 19, 10:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qw8w5m/global_carbon) has announced the addition of the "Global Carbon Fiber Reinforced Plastic (CFRP) Market 2015-2019" report to their offering. Global CFRP Market to Grow at a CAGR of 13.07% over the Period 2014-2019 The fluctuating price of fuel drives the market for electric and hybrid vehicles, in which CFRP materials are used as they are lightweight and balance the heavy engines and motors used in the body. The use of CFRP in the manufacture of high-performance vehicle components such as chassis, hoods, wheels, and roofs also drives market growth. According to the report, the fluctuating price of fuel drives the market for electric and hybrid vehicles, in which CFRP materials are used as they are lightweight and balance the heavy engines and motors used in the body. The use of CFRP in the manufacture of high-performance vehicle components such as chassis, hoods, wheels, and roofs also drives market growth. Further, the report states that the high cost of carbon fiber hinders market growth. Key Topics Covered - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Global CFRP Market - Market Segmentation by Type - Market Segmentation by Raw Material - Market Segmentation by Application - Geographical Segmentation - Key Leading Countries - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Composite Holding - Crosby Composites - Cytec Industries - DowAksa - Formosa Plastics - GKN Aerospace - Gurit Holdings - Hexcel - Hyosung - Kringlan Composites - Mitsubishi Rayon Carbon Fiber and Composite - Nippon Graphite Fibre - Plasan Carbon Composites - SGL Group - Teijin - Tencate - Toho Tenax America - Toray industries - Zoltek For more information visit http://www.researchandmarkets.com/research/qw...bal_carbon
CYT: 74.02 (+0.09)
Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021
M2 - Wed Aug 19, 3:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nl6c3p/stationary_oxygen) has announced the addition of Wintergreen Research, Inc's new report "Stationary Oxygen Concentrators: Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021" to their offering. Oxygen concentrator markets at $669.5 million in 2014 are anticipated to reach $2 billion dollars by 2021. Growth is a result of new competitors in the market, demand for the smaller lighter technology by patients, and the market need by for stationary devices at home even as portable devices provide greater mobility support for older people. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. Stationary oxygen concentrators are needed for night use by patients on portable oxygen concentrators during the day. People on oxygen wish to continue usual activities, the portable devices are useful for that during the day. Distributors are concentrated on determining which stationary oxygen concentrator supports patient lifestyle. Major factors driving the market for stationary oxygen concentrators include its ability to provide oxygen under all circumstances. The worldwide aging population. An increase in the number of people with COPD and other respiratory diseases. Advantages of newer stationary oxygen concentrator devices are that they weigh less, are somewhat quieter than toe older units, and are easy to use. They are generally affordable but reimbursement drives markets. There has been a quantum improvement in the home based stationary oxygen concentrator technology. Less weight, more power are the characteristics of the new stationary units. The huge jump in technology is illustrated by the effectiveness of the devices in providing improved patient lifestyle. Stationary concentrator systems are always used by a patient to supplement portable oxygen concentrators. Portable oxygen must be supplemented with standard large, bulky, and inefficient, heavy, and impractical stationary devices because the stationary devices provide a more stable source of oxygen during sleep. Key Topics Covered: 1. Stationary Oxygen Concentrator Market Description and Market Dynamics 2 Stationary Oxygen Concentrator Market Shares and Forecasts 3. Stationary Oxygen Concentrator Product Description 4 Stationary Oxygen Concentrator Technology 5 Stationary Oxygen Concentrator Company Profiles Market Leaders: - AirSep - Chart / Caire / SeQual - Invacare - Philips Respironics Market Participants: - Air Liquide - Braun and Company - CAIRE / SeQual Technologies - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - O2Concepts Oxlife - OSI Systems - ResMed - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Troope For more information visit http://www.researchandmarkets.com/research/nl...ary_oxygen Source: Wintergreen Research, Inc
IVC: 16.23 (-0.06), CFN: 59.91 (-0.06), TFX: 125.79 (+0.64), OSIS: 82.71 (+0.13)
Global Carbon Fiber Market 2015-2019 - Analyzes the Potential Opportunities and Significant Trends in the Industry
M2 - Tue Aug 18, 8:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fj9pwb/global_carbon) has announced the addition of the "Global Carbon Fiber Market: Trends and Opportunities (2015-2019)" report to their offering. The report titled Carbon Fiber Market: Trends & Opportunities (2015-2019), analyzes the potential opportunities and significant trends in the carbon fiber industry. The report provides detailed analysis of market sizing and growth of carbon fiber by various applications for the period 2010-2014. The Industrial segment is expected to be the fastest growing segment for the next 5 years, due to technical advances. Furthermore, in carbon fiber production, USA has the highest market share. The report also provides detailed market share analysis of the carbon fiber demand and supply. The market forecast in value terms for carbon fiber market has been provided for the period 2015 to 2019, considering 2014 as the base year. The report also provides compounded annual growth rate (% CAGR) for the forecast period 2015 to 2019. Over the next five years, Carbon fiber market revenues are forecasted to grow with the wide usage in the wind energy sector in the coming years. The report provides detailed country analysis of China carbon fiber market in terms of value, capacity and areas of application. And the report also profiles key market players such as Toray Industries Inc., Zoltek Companies Inc., Teijin Limited, Hexcel and Cytec Industries Inc. on the basis of attributes such as company overview, recent developments, strategies adopted by the market leaders to ensure growth, sustainability, financial overview and recent developments. Company Coverage - Toray Industries Inc. - Zoltek Companies Inc. - Teijin Limited - Hexcel - Cytec Industries Inc. Key Topics Covered: 1.Executive Summary 2. Carbon Fiber: An Introduction 3. Global Carbon Fiber Market: An Analysis 4. Global Carbon Fiber Market Share: An Analysis 5. Carbon Fiber Market of China: An Analysis 6. Market Dynamics: Carbon Fiber Market 7. Competitive Landscape:Carbon Fiber Market 8. Company Profiles:Carbon Fiber Market For more information visit http://www.researchandmarkets.com/research/fj...bal_carbon
CYT: 74.02 (+0.09)
